Table 2.
Characteristics of NMS cases.
| No. | Age, sex (M: Male, F: Female) | Disease | Drugs used | TA (mmHg) | Pulse (min) | Temperature (°C) | GCS | Clinical symptoms and findings | Outcome | Length of stay in hospital (Day) | Causes of death |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 47, F | Schizophrenia | Alprazolam, quetiapine, aripiprazole, paliperidone | 164/123 | 113 | 38.6 | 8 | Muscular rigidity, sweating, dysphagia, tremor, incontinence, altered consciousness, mutism | Death | 10 | Sepsis |
| 2 | 75, M | Schizophrenia | Biperiden, mirtazapine, paroxetine, amisulpride, clozapine, risperidone | 160/140 | 170 | 39.0 | 9 | Muscular rigidity, sweating, dysphagia, tremor, incontinence, altered consciousness, mutism | Death | 2 | Respiratory failure |
| 3 | 76, F | Parkinson | Levodopa (withdrwal), pramipexole, gabapentin, paroxetine, amitriptyline | 180/100 | 140 | 39.3 | 10 | Muscular rigidity, sweating, tremor, altered consciousness, mutism | Death | 42 | Sepsis |
| 4 | 42, M | Mental retardation | Biperiden, olanzapine | 170/100 | 117 | 38.4 | 12 | Muscular rigidity, sweating, tremor, altered consciousness | Recovery | 32 | |
| 5 | 43, F | Bipolar disorder | Biperiden, amitriptyline, lithium, phenothiazine, chlorpromazine, quetiapine | 90/60 | 122 | 39.1 | 11 | Muscular rigidity, sweating, tremor, altered consciousness, mutism | Recovery | 19 | |
| 6 | 64, F | Bipolar disorder | Valproic acid, lorazepam, haloperidol, quetiapine, olanzapine | 140/80 | 108 | 38.0 | 13 | Muscular rigidity, tremor, altered consciousness, | Recovery | 11 | |
| 7 | 20, F | Mental retardation | Risperidone, quetiapine | 110/80 | 80 | 39.0 | 11 | Muscular rigidity, dysphagia, tremor, incontinence altered consciousness, mutism | Recovery | 47 | |
| 8 | 44, M | Schizophrenia +Substance dependence |
Amisulpride | 120/70 | 84 | 38.6 | 12 | Muscular rigidity, sweating, tremor, altered consciousness, mutism | Recovery | 31 | |
| 9 | 18, F | Schizophrenia +acute psychosis |
Clonazepam, amisulpride, olanzapine | 100/80 | 112 | 38.2 | 12 | Muscular rigidity, sweating, tremor, altered consciousness, mutism | Recovery | 22 | |
| 10 | 32, M | Substance dependence | Lorazepam, quetiapine | 110/70 | 92 | 38 | 8 | Muscular rigidity, sweating, altered consciousness, mutism | Recovery | 54 | |
| 11 | 25, M | Mental retardation | Lorazepam, amisulpride | 140/90 | 88 | 37.9 | 13 | Muscular rigidity, sweating, dysphagia, altered consciousness, mutism | Recovery | 19 | |
| 12 | 40, F | Schizophrenia | Biperiden, mirtazapine, olanzapine | 100/60 | 130 | 38.5 | 13 | Altered consciousness mutism | Recovery | 92 | |
| 13 | 46, M | Delirium | Haloperidol, olanzapine | 145/90 | 125 | 38.5 | 12 | sweating, dysphagia, incontinence, altered consciousness, mutism | Recovery | 8 | |
| 14 | 23, K | Acute psychosis | Lorazepam, quetiapine, risperidone | 160/90 | 140 | 39.0 | 11 | Muscular rigidity, tremor, altered consciousness, mutism | Recovery | 33 | |
| 15 | 32,M | No characteristic | Metoclopramide | 140/100 | 120 | 40.0 | 10 | Muscular rigidity, sweating, dysphagia, tremor, incontinence, altered consciousness, mutism | Recovery | 20 | |
| 16 | 79, M | Dementia +Parkinson +Alzheimer |
Levodopa (withdrwal), pramipexole | 150/100 | 112 | 38.2 | 12 | Muscular rigidity, sweating, dysphagia, altered consciousness, mutism | Recovery | 10 | |
| 17 | 74, F | Parkinson | Levodopa, paroxetine, quetiapine | 150/100 | 81 | 37.7 | 10 | Muscular rigidity, sweating, dysphagia, tremor, altered consciousness, mutism | Recovery | 11 | |
| 18 | 65, M | Parkinson | Levodopa (withdrwal), paroxetine | 90/50 | 144 | 40.0 | 7 | Muscular rigidity, sweating, dysphagia, altered consciousness, mutism | Recovery | 9 |